array:24 [
  "pii" => "S0211699520300047"
  "issn" => "02116995"
  "doi" => "10.1016/j.nefro.2019.10.009"
  "estado" => "S300"
  "fechaPublicacion" => "2020-07-01"
  "aid" => "689"
  "copyright" => "Sociedad Española de Nefrología"
  "copyrightAnyo" => "2020"
  "documento" => "article"
  "crossmark" => 0
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2020;40:421-8"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S0211699520300291"
    "issn" => "02116995"
    "doi" => "10.1016/j.nefro.2019.12.004"
    "estado" => "S300"
    "fechaPublicacion" => "2020-07-01"
    "aid" => "700"
    "copyright" => "Sociedad Española de Nefrología"
    "documento" => "article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2020;40:429-39"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>"
      "titulo" => "The long noncoding RNA EMBP1 inhibits the tumor suppressor miR-9-5p and promotes renal cell carcinoma tumorigenesis"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "429"
          "paginaFinal" => "439"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "El ARN no codificante largo EMBP1 inhibe el supresor tumoral miR-9-5p y favorece la oncog&#233;nesis del carcinoma de c&#233;lulas renales"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0020"
          "etiqueta" => "Fig&#46; 4"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr4.jpeg"
              "Alto" => 4448
              "Ancho" => 3167
              "Tamanyo" => 805580
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">The EMBP1&#47;miR-9-5p axis affects tumor growth in an <span class="elsevierStyleItalic">in vivo</span> mouse xenograft model&#46; &#40;A&#41; Tumor volume analyzed after intra-tumoral injection of miR-9-5p mimic or control&#46; pcDNA6-transfected ACHN xenograft tumors &#40;with or without CCNE2 overexpression&#41; were injected with miR-9-5p mimic or control at an interval of three days&#44; starting from day 11 post-implantation&#46; &#40;B&#41; Images of tumors on day 39 post-implantation&#46; &#40;C&#44; D&#41; RT-qPCR analysis on extracted tumor RNA for &#40;C&#41; miR-9-5p expression and &#40;D&#41; CCNE2 expression&#46; &#40;E&#41; Tumor volume analyzed after intra-tumoral injection of siEMBP1 or control&#46; pcDNA6-transfected ACHN xenograft tumors &#40;with or without CCNE2 overexpression&#41; were injected with siRNA or control at an interval of three days&#44; starting from day 11 post-implantation&#46; &#40;F&#41; Images of tumors on day 39 post-implantation&#46; &#40;G&#8211;I&#41; RT-qPCR analysis on extracted tumor RNA for &#40;G&#41; EMBP1 expression&#44; &#40;H&#41; primary &#40;pri&#41;-miR-9&#44; precursor &#40;pre&#41;-miR-9&#44; and mature miR-9-5p expression&#44; and &#40;I&#41; CCNE2 expression&#46; &#40;J&#41; Diagrammatic representation showing how EMBP1&#39;s negative regulation of miR-9-5p may promote pro-proliferative&#44; migratory&#44; and invasive pathways in RCC cells&#46; Values are expressed as means<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>SEMs&#46; &#42;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;05&#44; &#42;&#42;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;01 <span class="elsevierStyleItalic">vs&#46;</span> Con &#91;Student&#39;s <span class="elsevierStyleItalic">t</span>-test&#93;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Yejing Hong, Zhongming Yuan, Rongzhong Huang, Zhiqin Wu, Yongyong Li"
          "autores" => array:5 [
            0 => array:2 [
              "nombre" => "Yejing"
              "apellidos" => "Hong"
            ]
            1 => array:2 [
              "nombre" => "Zhongming"
              "apellidos" => "Yuan"
            ]
            2 => array:2 [
              "nombre" => "Rongzhong"
              "apellidos" => "Huang"
            ]
            3 => array:2 [
              "nombre" => "Zhiqin"
              "apellidos" => "Wu"
            ]
            4 => array:2 [
              "nombre" => "Yongyong"
              "apellidos" => "Li"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699520300291?idApp=UINPBA000064"
    "url" => "/02116995/0000004000000004/v2_202009020626/S0211699520300291/v2_202009020626/en/main.assets"
  ]
  "itemAnterior" => array:20 [
    "pii" => "S021169951930195X"
    "issn" => "02116995"
    "doi" => "10.1016/j.nefro.2019.10.004"
    "estado" => "S300"
    "fechaPublicacion" => "2020-07-01"
    "aid" => "678"
    "copyright" => "Sociedad Espa&#241;ola de Nefrolog&#237;a"
    "documento" => "article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2020;40:414-20"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 366
      "formatos" => array:3 [
        "EPUB" => 33
        "HTML" => 197
        "PDF" => 136
      ]
    ]
    "es" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original</span>"
      "titulo" => "Seguridad renal de espironolactona en pacientes con hipertensi&#243;n arterial resistente"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "414"
          "paginaFinal" => "420"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Renal safety outcomes of spironolactone in patients with resistant hypertension"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0010"
          "etiqueta" => "Figura 2"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr2.jpeg"
              "Alto" => 3620
              "Ancho" => 2167
              "Tamanyo" => 348385
            ]
          ]
          "descripcion" => array:1 [
            "es" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Variaci&#243;n de creatinina plasm&#225;tica &#40;A&#41;&#44; filtrado glomerular estimado &#40;B&#41; y potasio plasm&#225;tico &#40;C&#41; durante el tratamiento con espironolactona&#46;</p> <p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">C-I&#58; cohorte retrospectiva&#59; C-II&#58; cohorte prospectiva&#59; Creap&#58; creatinina plasm&#225;tica&#59; FGe&#58; filtrado glomerular estimado&#59; Kp&#58; potasio plasm&#225;tico&#46;</p> <p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">&#42;p<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#44;05 vs&#46; basal&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Isabel Galceran, Susana V&#225;zquez, Xavier Dur&#225;n, Sara Out&#243;n, Julio Pascual, Anna Oliveras"
          "autores" => array:6 [
            0 => array:2 [
              "nombre" => "Isabel"
              "apellidos" => "Galceran"
            ]
            1 => array:2 [
              "nombre" => "Susana"
              "apellidos" => "V&#225;zquez"
            ]
            2 => array:2 [
              "nombre" => "Xavier"
              "apellidos" => "Dur&#225;n"
            ]
            3 => array:2 [
              "nombre" => "Sara"
              "apellidos" => "Out&#243;n"
            ]
            4 => array:2 [
              "nombre" => "Julio"
              "apellidos" => "Pascual"
            ]
            5 => array:2 [
              "nombre" => "Anna"
              "apellidos" => "Oliveras"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S2013251420300870"
        "doi" => "10.1016/j.nefroe.2020.08.001"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251420300870?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S021169951930195X?idApp=UINPBA000064"
    "url" => "/02116995/0000004000000004/v2_202009020626/S021169951930195X/v2_202009020626/es/main.assets"
  ]
  "en" => array:20 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>"
    "titulo" => "<span class="elsevierStyleItalic">SPTB</span> related spherocytosis in a three-generation family presenting with kidney failure in adulthood due to co-occurrence of <span class="elsevierStyleItalic">UMOD</span> disease causing variant"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "421"
        "paginaFinal" => "428"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Anamarija Meglic, Marusa Debeljak, Jernej Kovac, Alenka Trampus Bakija, Vladan Rajic, Nika Kojc, Katarina Trebusak Podkrajsek"
        "autores" => array:7 [
          0 => array:3 [
            "nombre" => "Anamarija"
            "apellidos" => "Meglic"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Marusa"
            "apellidos" => "Debeljak"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Jernej"
            "apellidos" => "Kovac"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "Alenka"
            "apellidos" => "Trampus Bakija"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "Vladan"
            "apellidos" => "Rajic"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
          5 => array:3 [
            "nombre" => "Nika"
            "apellidos" => "Kojc"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "aff0020"
              ]
            ]
          ]
          6 => array:4 [
            "nombre" => "Katarina"
            "apellidos" => "Trebusak Podkrajsek"
            "email" => array:1 [
              0 => "katarina.trebusakpodkrajsek@mf.uni-lj.si"
            ]
            "referencia" => array:3 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">e</span>"
                "identificador" => "aff0025"
              ]
              2 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:5 [
          0 => array:3 [
            "entidad" => "University Medical Centre Ljubljana&#44; University Children&#39;s Hospital&#44; Department of Nephrology&#44; Ljubljana&#44; Slovenia"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "University Medical Centre Ljubljana&#44; University Children&#39;s Hospital&#44; Institute for Special Laboratory Diagnostics&#44; Ljubljana&#44; Slovenia"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "University Medical Centre Ljubljana&#44; University Children&#39;s Hospital&#44; Department of Haematology and Oncology&#44; Ljubljana&#44; Slovenia"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
          3 => array:3 [
            "entidad" => "University of Ljubljana&#44; Faculty of Medicine&#44; Institute of Pathology&#44; Ljubljana&#44; Slovenia"
            "etiqueta" => "d"
            "identificador" => "aff0020"
          ]
          4 => array:3 [
            "entidad" => "University of Ljubljana&#44; Faculty of Medicine&#44; Institute of Biochemistry&#44; Ljubljana&#44; Slovenia"
            "etiqueta" => "e"
            "identificador" => "aff0025"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "<span class="elsevierStyleItalic">Corresponding author</span>&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Esferocitosis relacionada con SPTB en tres generaciones de una familia con insuficiencia card&#237;aca en la edad adulta debido a la presentaci&#243;n conjunta de la variante de UMOD causante de la enfermedad"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0020"
        "etiqueta" => "Fig&#46; 4"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr4.jpeg"
            "Alto" => 1380
            "Ancho" => 907
            "Tamanyo" => 346603
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">Pathology picture of the affected kidney biopsy in the family member &#40;II-3&#41;&#58; &#40;A&#41; Segmental glomerulosclerosis and pericapsular fibrosis accompanied by interstitial fibrosis and tubular atrophy &#40;Periodic acid-Schiff stain&#44; 100&#215;&#41;&#46; &#40;B&#41; Marked tubular atrophy in medulla &#40;Trichrome stain&#44; 100&#215;&#41;&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Hereditary spherocytosis &#40;HS&#41; is a common type of hereditary haemolytic anaemia&#46; It is clinically and genetically heterogeneous disorder&#44; with spherocytosis&#44; anaemia&#44; jaundice and splenomegaly as typical clinical characteristics&#46;<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">1</span></a> Clinical severity is variable with most patients having a well-compensated haemolytic anaemia&#46; Some individuals are asymptomatic&#44; whereas others have severe haemolytic anaemia requiring erythrocyte transfusion&#46; Patients are classified by clinical features as severe&#44; moderate or mild using the criteria establish by Eber SW&#46;<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">2</span></a> The assessment should be issued when the patient is in a stable baseline state&#44; as with the undercurrent illness the severity may be overestimated&#46; Children with severe HS are rare &#40;about 5&#37;&#41;&#46; They are constantly anaemic and may be transfusion dependent&#44; especially in the first few years of life&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">The primary causes of the disease are abnormalities of the red blood cell membrane structural proteins leading to the loss of membrane surface area&#44; erythrocytes deformability and decrease of stability&#44; finally resulting in haemolysis&#46; The aetiology is related to the genes encoding proteins involved in the interaction between the erythrocyte membrane and the lipid bilayer&#44; namely ankyrin &#40;<span class="elsevierStyleItalic">ANK1</span>&#41;&#44; &#945;1-spectrin &#40;<span class="elsevierStyleItalic">SPTA1</span>&#41;&#44; &#946;I-spectrin &#40;<span class="elsevierStyleItalic">SPTB</span>&#41;&#44; band 3 &#40;<span class="elsevierStyleItalic">SLC4A1</span>&#41; and protein 4&#46;2 &#40;<span class="elsevierStyleItalic">EPB42</span>&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">3</span></a> Variants in <span class="elsevierStyleItalic">SPTB</span> gene are causing HS type 2 &#40;MIM&#35;<a href="omim:616649">616649</a>&#41; and are inherited in an autosomal dominant manner&#46; They are responsible for approximately 25&#37; of HS cases in the United States of America and Europe presenting with mild to moderately severe disease where transfusion is usually not needed&#46;<a class="elsevierStyleCrossRefs" href="#bib0100"><span class="elsevierStyleSup">1&#44;3</span></a> Sporadically&#44; large genomic deletions of <span class="elsevierStyleItalic">SPTB</span> gene were associated to psychomotor developmental delay and autism<a class="elsevierStyleCrossRefs" href="#bib0115"><span class="elsevierStyleSup">4&#44;5</span></a> while <span class="elsevierStyleItalic">SPTB</span> gene substitution was associated to prenatal hydrops fetalis&#46;<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">6</span></a> Additionally&#44; variants in <span class="elsevierStyleItalic">SPTB</span> gene were associated to hereditary elliptocytosis &#40;MIM&#35;<a href="omim:617948">617948</a>&#41;&#46; Among kidney disease&#44; isolated cases of nephrotic syndrome due to membranoproliferative glomerulonephritis<a class="elsevierStyleCrossRef" href="#bib0130"><span class="elsevierStyleSup">7</span></a> and macroscopic haematuria with proteinuria due to IgA nephropathy<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">8</span></a> were reported in patients with HS&#46; Here we present a three-generation family with seven patients with spherocytosis due to the novel variant in <span class="elsevierStyleItalic">SPTB</span> gene &#40;<a href="ncbi-n:NM_001024858">NM&#95;001024858</a>&#59; c&#46;4796G&#62;A&#59; p&#46;Trp1599Ter&#41;&#46; Among the patients in the family&#44; two adults had end-stage kidney disease and one chronic kidney disease &#40;CKD&#41; stage 4 with histopathologicaly unspecific findings of interstitial fibrosis and focal segmental glomerulosclerosis &#40;FSGS&#41; that was later on attributed to tubulo-interstitial kidney disease due to disease causing <span class="elsevierStyleItalic">UMOD</span> variant&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Material and methods</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Patients</span><p id="par0015" class="elsevierStylePara elsevierViewall">Initially&#44; two Slovenian paediatric patients with spherocytosis were referred to the paediatric nephrologist at the outpatient clinic of the Department for Nephrology at the University Children&#39;s Hospital in Ljubljana&#44; Slovenia&#44; because of the positive family history of CKD in their father&#44; paternal grandmother and uncle&#46; After initial clinical examination&#44; we issued standard laboratory and radiological investigations to evaluate the kidney function&#44; electrolytic disturbances&#44; acid-base status and red blood cell status properties&#46; Additionally&#44; detailed family history regarding renal and haematological diseases was assessed&#46; Later on&#44; all seven affected family members were invited for additional evaluation&#46; Participants consented to the study&#44; which was conducted according to the principles in the Declaration of Helsinki&#46;</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Genetic analysis</span><p id="par0020" class="elsevierStylePara elsevierViewall">Genomic DNA of all affected family members was isolated from peripheral blood samples using FlexiGene DNA isolation kit &#40;Qiagen&#44; Hilden&#44; Germany&#41;&#46; To evaluate the genetic cause of the spherocytosis and CKD in the family a targeted next generation sequencing &#40;NGS&#41; was conducted in both siblings and their affected father and paternal grandmother&#46; We used TruSightOne Sequencing Panel on the MiSeq platform desktop sequencer coupled with MiSeq Reagent kit v3 &#40;all Illumina&#44; USA&#41; followed by on-board primary analysis&#46; A list of rare genetic variants &#40;minor allele frequency &#60;1&#37;&#41; in 5 genes related to HS&#44; 51 genes related to inherited glomerular disorders with FSGS or 4 genes related to autosomal dominant tubulo-interstitial kidney disease &#40;ADTKD&#41; &#40;<a class="elsevierStyleCrossRef" href="#sec0065">Supplementary material 1</a>&#41; was filtered with Variant Studio 2&#46;3 software &#40;Illumina&#44; USA&#41;&#46; Variants that were identified as possibly causative were confirmed by targeted Sanger sequencing using custom oligonucleotides&#44; BigDye Terminator v3&#46;1 sequencing kit and ABI Genetic Analyser 3500 &#40;both Applied Biosystems&#44; USA&#41; in all family members&#46;</p></span></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Results</span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Patients</span><p id="par0025" class="elsevierStylePara elsevierViewall">Family pedigree with major clinical manifestations and detected disease-causing variants was summarised in <a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#46; All family members with spherocytosis had 1&#8211;6&#37; of spherocytes in the peripheral blood smear&#46; Additionally&#44; Howell Jolley bodies and occasional basophile punctuations were present &#40;<a class="elsevierStyleCrossRef" href="#fig0010">Fig&#46; 2</a>&#41;&#46; Mean cell volume &#40;MCV&#41; values were lower than in normal population ranged from 74 to 86<span class="elsevierStyleHsp" style=""></span>fL and median haemoglobin concentrations were 116<span class="elsevierStyleHsp" style=""></span>g&#47;L &#40;95&#8211;163&#41;&#46; Osmotic fragility test showed increased RBC membrane fragility with tailed sigmoid curve in all patients with HS but patients II-1 and III-4&#44; while RBC band 3 protein fluorescence staining with eosin-5-maleimide &#40;EMA&#41; was significantly decreased in all patients&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0030" class="elsevierStylePara elsevierViewall">Both initially evaluated siblings &#40;subject III-1 and III-2&#41; had normal kidney function and blood pressure&#44; no proteinuria or haematuria&#44; no electrolytic disturbances or acid-base status abnormalities&#46; The ultrasound exam of urinary tract was normal&#46; The older sibling&#44; 16-year-old girl &#40;subject III-1&#41; had so far only one haemolytic crisis that needed transfusion&#44; the younger&#44; 12-year-old boy &#40;subject III-2&#41; had none&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">Nephrologist followed the children&#39;s 42-year-old father with spherocytosis &#40;subject II-2&#41; due to deterioration of the renal function with hypertension&#46; Splenectomy was performed when he was 22 years old&#44; after one of the many haemolytic crises&#46; After splenectomy haemolytic crises did not repeat&#46; He had hyperuricemia without clinical presentation of gout&#46; When renal biopsy was performed&#44; glomerular filtration rate &#40;GFR&#41; 17<span class="elsevierStyleHsp" style=""></span>ml&#47;min&#47;1&#46;73<span class="elsevierStyleHsp" style=""></span>m<span class="elsevierStyleSup">2</span>&#44; electrolyte imbalance of potassium and phosphate were described and mild proteinuria &#40;520<span class="elsevierStyleHsp" style=""></span>mg&#47;day&#41;&#46; By ultrasonography&#44; his kidney appeared hyper-echogenic and were smaller than expected for an adult male &#40;8<span class="elsevierStyleHsp" style=""></span>cm&#41;&#46; Histopathological findings showed rather unspecific changes including diffuse 70&#37; interstitial fibrosis and tubular atrophy with scarce interstitial infiltrate composed of lymphocytes and monocytes&#44; and advanced glomerulosclerosis in 75&#37; of glomeruli &#40;70&#37; global glomerulosclerosis and 5&#37; segmental glomerulosclerosis&#41; &#40;<a class="elsevierStyleCrossRef" href="#fig0015">Fig&#46; 3</a>&#41;&#44; while no cysts were detected&#46; Electron microscopy revealed normal ultrastructure of glomerular basement membrane with minimal segmental 5&#37; podocyte effacement&#46; Immunofluorescence was unremarkable&#46; He had kidney transplantation three years later&#44; following few months of dialysis&#46; Protocol biopsy one year after transplantation revealed well-functioning kidney graft without signs of rejection&#44; his uric acid was normal without therapy&#46;</p><elsevierMultimedia ident="fig0015"></elsevierMultimedia><p id="par0040" class="elsevierStylePara elsevierViewall">The siblings&#8217; paternal grandmother with spherocytosis &#40;subject I-1&#41; had splenectomy when she was about 40 years old&#46; She started with dialysis when she was about 55 years old&#46; She had hyperuricemia that was well controlled by allopurinol and diet&#46; At age of 58&#44; she had kidney transplantation and experienced T-cell mediated rejection 4 months later&#46; She presented with <span class="elsevierStyleItalic">Pneumocystis jirovecii</span> pneumonia and CMV disease resulting in decrease of immunosuppressive therapy and finally lost her graft 3 years after transplantation due to chronic active T-cell and vascular rejection&#46; At the time&#44; she had no follow-up by the nephrologist before the kidney failure&#44; no renal biopsy and there is no available data regarding prior development of her kidney disease&#46; Recently she had passed away due to a stroke in her seventies&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">Another family member&#44; 32-year-old uncle of the siblings&#44; namely their father&#39;s brother &#40;subject II-3&#41;&#44; had splenectomy at age of 12 after several mild haemolytic crises&#46; Later on&#44; the diagnosis of CKD was set&#46; He had gout with many attacks despite of allopurinol therapy and diet&#46; Light microscopy detected 40&#37; interstitial fibrosis and tubular atrophy affecting cortex and medulla with lack of functioning tubules particularly in medulla without any cysts&#46; Accompanied 25&#37; glomerulosclerosis and pericapsular fibrosis of glomeruli indicated secondary involvement due to tubulointerstitial damage &#40;<a class="elsevierStyleCrossRef" href="#fig0020">Fig&#46; 4</a>&#41;&#46; Immunofluorescence was unremarkable&#46; Additionally&#44; his 2-year- and 4-year-old sons &#40;subjects III-3 and III-4&#41; had spherocytosis with no haemolytic crisis so far and no clinical or echocardiographic signs of kidney disease&#46; Their creatinine clearances were normal&#44; they had no proteinuria&#44; but both had high serum uric acid levels and low fractional excretions of urinary uric acid&#46; Detailed description of CKD development in adult patients over their life span was summarised in <a class="elsevierStyleCrossRef" href="#fig0025">Fig&#46; 5</a>&#46;</p><elsevierMultimedia ident="fig0020"></elsevierMultimedia><elsevierMultimedia ident="fig0025"></elsevierMultimedia></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Genetic analysis</span><p id="par0050" class="elsevierStylePara elsevierViewall">The analysis revealed that both index patients&#44; their father&#44; paternal grandmother&#44; father&#39;s younger brother and his two children were heterozygous for the <span class="elsevierStyleItalic">SPTB</span> variant NM&#95;001024858&#58;c&#46;4796G&#62;A resulting in premature termination codon at the position 1599 &#40;NP&#95;001020029&#46;1&#58;p&#46;Trp1599Ter&#41; &#40;<a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#41;&#46; The variant had so far not been reported in patients with spherocytosis nor in apparently healthy population while <span class="elsevierStyleItalic">in silico</span> tools were predicting it to be pathological &#40;Mutation taster&#44; CADD score 45&#41;&#46; According to the ACMG&#47;AMP 2015 guidelines<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">9</span></a> the variant was classified as pathological with the following grades&#58; PVS1 &#40;null variant&#41;&#44; PM2 &#40;absent from general population&#41;&#44; PP1 &#40;co-segregation with the disease in multiple affected family members in gene definitely known to cause the disease&#41;&#44; PP3 &#40;multiple lines of computational evidence supporting the deleterious effect&#41;&#46; Additionally&#44; we performed NGS based analysis of genes related to inherited glomerular disorders and ADTKD&#46; Father of the index patients&#44; paternal grandmother&#44; father&#39;s brother and his two children were heterozygous for the <span class="elsevierStyleItalic">UMOD</span> variant NM&#95;003361&#46;3&#58;c&#46;552G&#62;C resulting in substitution of tryptophan to cysteine at the position 184 &#40;NP&#95;003352&#46;2&#58;p&#46;Trp184Cys&#41; &#40;<a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#41;&#46; This variant has already been reported in patients with ADTKD &#40;HGMD acc&#46; nr&#46; CM118889&#41;<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">10</span></a> and was not present in index patients nor in their mother&#46;</p></span></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Discussion</span><p id="par0055" class="elsevierStylePara elsevierViewall">HS is a common type of hereditary haemolytic anaemia&#44; rarely accompanied by renal manifestations&#46;<a class="elsevierStyleCrossRef" href="#bib0130"><span class="elsevierStyleSup">7</span></a> We present a family with seven members presenting with HS due to the novel <span class="elsevierStyleItalic">SPTB</span> variant p&#46;Trp1599Ter suspected to cause &#946;I-spectrin deficiency&#46; In the same family&#44; all three affected adult family members had CKD that was later on attributed to the known <span class="elsevierStyleItalic">UMOD</span> gene variant p&#46;Trp184Cys&#46;</p><p id="par0060" class="elsevierStylePara elsevierViewall">Contrary to the HS in sickle cell disease &#40;SCD&#41;&#44; another type of haemolytic anaemia&#44; numerous renal syndromes were described&#44; including increased GFR&#44; acute renal failure&#44; renal tubular disease&#44; chronic renal insufficiency&#44; renal tubular acidosis and others as reviewed in Pham et al&#46;<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">11</span></a> Acute kidney injury during SCD pain crisis may be an important risk factor for developing CKD&#46;<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">12</span></a> Development of kidney disease in SCD is not fully elucidated&#46; It is associated with oxidative stress caused by the vaso-occlusive episodes&#44; ischaemia-reperfusion injury and the associated chronic inflammatory response&#44; glomerular hyperfiltration and chronic exposure of renal tubular epithelium to high levels of filtered plasma proteins due to proteinuria&#44; as reviewed by Wesson&#46;<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">13</span></a> Proximal tubule dysfunction&#44; including tubular proteinuria&#44; is a significant complication in SCD that can eventually lead to CKD&#46; Haemoglobin dimers released from red blood cells upon haemolysis are filtered into the kidney and internalised by megalin&#47;cubilin receptors into proximal tubule cells&#46; Proximal tubule cells are especially sensitive to haem toxicity and tubular dysfunction in SCD is thought to result from prolonged exposure to filtered hemoglobine&#46;<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">14</span></a> The mechanism behind the development of kidney disease in HS is not clear and might be related to the mechanism in SCD&#44; since haemolytic crisis are probably the initiators of its development in both cases&#46; Involvement of renal cortex and medulla in the absence of other known causes of medullary tissue remodelling &#40;diabetes&#44; chronic infections&#44; NSAIDS and congenital disorders&#41; suggested haemolysis as one of the potentially pathogenic mechanism of tubular and&#47;or vascular injury leading to interstitial fibrosis and secondary glomerulosclerosis&#46;</p><p id="par0065" class="elsevierStylePara elsevierViewall">In here presented family&#44; we initially speculated that haem toxicity was the cause of the CKD&#44; especially since it had an onset in the adulthood after many haemolytic crises&#46; Nevertheless&#44; to eliminate the less probable existence of additional genetic factors that could contribute to the co-occurrence of the renal disease&#44; we have analysed genes associated to the inherited glomerular disorders and ADTKD&#46; To our surprise&#44; we have identified a variant p&#46;Trp184Cys in <span class="elsevierStyleItalic">UMOD</span> gene in all three adult patients with kidney failure&#46; It was previously reported in 3 members of a Caucasian family with ADTKD&#44; but their clinical presentation was not individually described&#46;<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">15</span></a> In general&#44; early onset hyperuricemia is a hallmark of the ADTKD due to UMOD deficiency&#44; where renal survival and clinical characteristic are extremely variable even in patients in the same family&#46; Disease causing <span class="elsevierStyleItalic">UMOD</span> variants are resulting in deficient production of functional uromodulin normally expressed in tubular cells and intracellular deposition of mutant uromodulin&#46; This is leading to accelerated tubular damage and consequently end-stage renal kidney disease&#46;<a class="elsevierStyleCrossRef" href="#bib0175"><span class="elsevierStyleSup">16</span></a> Renal biopsy in two adult patients revealed rather unspecific histological changes including interstitial fibrosis&#44; tubular atrophy&#44; glomerulosclerosis and normal podocytes without foot process effacement even in advanced chronic tubulointerstitial changes&#44; which pointed towards tubules&#47;interstitium as primarily affected compartment and is in accordance with the UMOD deficiency&#46; They presented with low proteinuria suggesting FSGS as secondary glomerular changes due to hyperfiltration in remaining overloaded glomeruli&#46; Other risk factors &#40;<span class="elsevierStyleItalic">i&#46;e&#46;</span>&#58; low birth weight&#44; renal asymmetry&#44; obesity&#44; drugs&#44; inherited glomerular disorders&#41; for FSGS development were not present&#46; In addition&#44; two paediatric patients&#44; namely subjects III-3 and III-4&#44; had the same <span class="elsevierStyleItalic">UMOD</span> disease-causing variant&#46; Currently they have no reported haemolytic crises and normal kidney function&#44; but both have high serum uric acid&#44; low fractional excretion of urinary uric acid and low serum uromodulin level confirming deficient production of functional uromodulin&#46;</p><p id="par0070" class="elsevierStylePara elsevierViewall">NGS based genetic testing approach has proved useful as a first-line approach in identification of the genetic aetiology of inherited haemolytic anaemias where several genes can be candidates to be causative&#46;<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">17</span></a> Furthermore&#44; in cases with complex clinical manifestations that cannot be directly attributed to one disorder NGS enables analysis of all genes associated to individual manifestation in the same experiment without the need of the strict preselection&#46; This proofed to be extremely valuable in here reported family with co-occurrence of two rare inherited disorders with the clinical onset in different stages of life&#46; Furthermore&#44; the importance of the valid clinical evaluation of the index patients and their family members prior the NGS analysis is well recognised&#46; In here presented family it was crucial since index patients had no kidney disease&#44; but the genetic and clinical evaluation of the family enabled recognition of UMOD related ADTKD in their junior cousins with currently normal kidney function&#46; Consequently&#44; their renal function and serum uric acid level will be closely monitored in order to timely introduce hyperuricemia treatment&#46;<a class="elsevierStyleCrossRefs" href="#bib0185"><span class="elsevierStyleSup">18&#44;19</span></a> This is emphasising the importance of serum uric acid detection in routine laboratory screening of paediatric patients in order to identify early signs of tubular injury indicating possible ADTKD&#46;</p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Conclusions</span><p id="par0075" class="elsevierStylePara elsevierViewall">The co-occurrence of any two rare inherited disorders is extremely rare&#44; while to our knowledge the co-occurrence of genetically confirmed HS and ADTKD has not been previously reported&#46; It is not possibly to evaluate whether the haemolytic crises due to HS are influencing the progression of the UMOD related renal disease&#44; especially&#44; since the UMOD related kidney disease characteristics in general and in here presented family &#40;<a class="elsevierStyleCrossRef" href="#fig0025">Fig&#46; 5</a>&#41; are extremely variable&#46; Nevertheless&#44; the observed kidney disease in the family is warranting the regular nephrological examinations in paediatric patients in the family in order to recognise elevated serum uric acid as the first signs of tubular dysfunction&#44; since early onset of hyperuricemia treatment may slow the progression of subsequent kidney disease&#46; The future clinical course in index patients with HS and their two cousins with co-occurrence of HS and <span class="elsevierStyleItalic">UMOD</span> disease-causing variant will highlight the potential role of UMOD related disease as well as HS on kidney function&#46; Clinical data of five patients of different ages with the co-occurrence of two genetic disorders is extremely valuable and my shed a light on the complex pathophysiology of the genetically based co-morbidity&#46;</p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Funding</span><p id="par0080" class="elsevierStylePara elsevierViewall">The study was supported by the financial support from the <span class="elsevierStyleGrantSponsor" id="gs1">Slovenian Research Agency</span> &#40;research core funding <span class="elsevierStyleGrantNumber" refid="gs1">P3-0343</span> and <span class="elsevierStyleGrantNumber" refid="gs1">P1-0170</span>&#41;&#46;</p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0130">Conflict of interest</span><p id="par0085" class="elsevierStylePara elsevierViewall">None&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:13 [
        0 => array:3 [
          "identificador" => "xres1380133"
          "titulo" => "Abstract"
          "secciones" => array:5 [
            0 => array:2 [
              "identificador" => "abst0005"
              "titulo" => "Background"
            ]
            1 => array:2 [
              "identificador" => "abst0010"
              "titulo" => "Objective"
            ]
            2 => array:2 [
              "identificador" => "abst0015"
              "titulo" => "Methods"
            ]
            3 => array:2 [
              "identificador" => "abst0020"
              "titulo" => "Results"
            ]
            4 => array:2 [
              "identificador" => "abst0025"
              "titulo" => "Conclusions"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec1267477"
          "titulo" => "Keywords"
        ]
        2 => array:2 [
          "identificador" => "xpalclavsec1267476"
          "titulo" => "Abbreviations"
        ]
        3 => array:3 [
          "identificador" => "xres1380132"
          "titulo" => "Resumen"
          "secciones" => array:5 [
            0 => array:2 [
              "identificador" => "abst0030"
              "titulo" => "Antecedentes"
            ]
            1 => array:2 [
              "identificador" => "abst0035"
              "titulo" => "Objetivo"
            ]
            2 => array:2 [
              "identificador" => "abst0040"
              "titulo" => "Metodolog&#237;a"
            ]
            3 => array:2 [
              "identificador" => "abst0045"
              "titulo" => "Resultados"
            ]
            4 => array:2 [
              "identificador" => "abst0050"
              "titulo" => "Conclusiones"
            ]
          ]
        ]
        4 => array:2 [
          "identificador" => "xpalclavsec1267475"
          "titulo" => "Palabras clave"
        ]
        5 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introduction"
        ]
        6 => array:3 [
          "identificador" => "sec0010"
          "titulo" => "Material and methods"
          "secciones" => array:2 [
            0 => array:2 [
              "identificador" => "sec0015"
              "titulo" => "Patients"
            ]
            1 => array:2 [
              "identificador" => "sec0020"
              "titulo" => "Genetic analysis"
            ]
          ]
        ]
        7 => array:3 [
          "identificador" => "sec0025"
          "titulo" => "Results"
          "secciones" => array:2 [
            0 => array:2 [
              "identificador" => "sec0030"
              "titulo" => "Patients"
            ]
            1 => array:2 [
              "identificador" => "sec0035"
              "titulo" => "Genetic analysis"
            ]
          ]
        ]
        8 => array:2 [
          "identificador" => "sec0040"
          "titulo" => "Discussion"
        ]
        9 => array:2 [
          "identificador" => "sec0045"
          "titulo" => "Conclusions"
        ]
        10 => array:2 [
          "identificador" => "sec0050"
          "titulo" => "Funding"
        ]
        11 => array:2 [
          "identificador" => "sec0055"
          "titulo" => "Conflict of interest"
        ]
        12 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2019-04-19"
    "fechaAceptado" => "2019-10-27"
    "PalabrasClave" => array:2 [
      "en" => array:2 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec1267477"
          "palabras" => array:6 [
            0 => "Hereditary spherocytosis"
            1 => "Tubulo-interstitial kidney disease"
            2 => "&#946;I-spectrin"
            3 => "UMOD"
            4 => "Chronic kidney disease"
            5 => "Next generation sequencing"
          ]
        ]
        1 => array:4 [
          "clase" => "abr"
          "titulo" => "Abbreviations"
          "identificador" => "xpalclavsec1267476"
          "palabras" => array:13 [
            0 => "ANK1"
            1 => "ADTKD"
            2 => "BUN"
            3 => "CKD"
            4 => "EPB42"
            5 => "FSGS"
            6 => "GFR"
            7 => "HS"
            8 => "NGS"
            9 => "SCD"
            10 => "SPTA1"
            11 => "SPTB"
            12 => "SLC4A1"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec1267475"
          "palabras" => array:6 [
            0 => "Esferocitosis hereditaria"
            1 => "Nefropat&#237;a tubulointersticial"
            2 => "Gen de la espectrina &#946;I"
            3 => "UMOD"
            4 => "Nefropat&#237;a cr&#243;nica"
            5 => "Secuenciaci&#243;n de nueva generaci&#243;n"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:3 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Background</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Hereditary spherocytosis is clinically and genetically heterogeneous disorder and its clinical characteristics are spherocytosis&#44; anaemia&#44; jaundice and splenomegaly&#46; The aetiology is associated to the genes encoding proteins involved in the interaction between the erythrocyte membrane and the lipid bilayer&#46; Causative variants in &#946;I-spectrin &#40;<span class="elsevierStyleItalic">SPTB</span>&#41; gene presenting as mild to moderately severe disease are responsible for approximately 25&#37; cases in the USA and Europe&#46; Among kidney disease&#44; isolated cases of nephrotic syndrome due to membranoproliferative glomerulonephritis and macroscopic haematuria with proteinuria due to IgA nephropathy were previously reported in patients with SPTB deficiency&#46;</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Objective</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Seven patients from the same family with spherocytosis were evaluated to assess the kidney failure presented in all affected adult patients&#46;</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Methods</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Clinical&#44; radiological and laboratory investigations were issued to evaluate the spherocytosis and kidney disease&#46; In selected patients&#44; we also performed genetics testing with next generation sequencing of genes related to hereditary spherocytosis&#44; inherited glomerular disorders and tubulo-interstitial kidney disease&#46;</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Results</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Among the family members with spherocytosis&#44; two adults had end-stage kidney disease and one chronic kidney disease stage 4 with unspecific histopathological findings of interstitial fibrosis&#47;tubular atrophy and glomerulosclerosis&#46; At the time&#44; there were no signs of kidney disease present in four paediatric patients&#46; Novel nonsense variant in <span class="elsevierStyleItalic">SPTB</span> gene &#40;<span class="elsevierStyleInterRef" id="intr0005" href="ncbi-n:NM_001024858">NM&#95;001024858</span>&#59; c&#46;4796G&#62;A&#59; p&#46;Trp1599Ter&#41; was detected in all family members with spherocytosis and was predicted to be disease causing&#46; Furthermore&#44; all adult patients with kidney failure and two paediatric cousins of the index patients were heterozygous for the <span class="elsevierStyleItalic">UMOD</span> gene variant &#40;NM&#95;003361&#46;3&#58;c&#46;552G&#62;C&#44; NP&#95;003352&#46;2&#58;p&#46;Trp184Cys&#41; previously reported in patients with tubulo-interstitial kidney disease&#46; <span class="elsevierStyleItalic">UMOD</span> variant was not present in the index patients&#46;</p></span> <span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Conclusions</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">The co-occurrence of any two rare inherited disorders is extremely rare&#44; while to our knowledge the co-occurrence of genetically confirmed HS and autosomal dominant tubulo-interstitial kidney disease &#40;ADTKD&#41; has previously not been reported&#46; It is not possibly to evaluate whether the haemolytic crises due to HS are influencing the progression of the UMOD related renal disease&#44; since the UMOD related ADTKD characteristics in general and in here presented family are extremely variable&#46; Nevertheless&#44; the observed kidney disease in the family is warranting the regular nephrological examinations in UMOD positive paediatric patients in the family in order to recognise hyperuricemia and treat it as early as possible&#46; This is emphasising the importance of serum uric acid detection in routine laboratory screening of paediatric patients in order to identify early signs of tubular injury indicating possible ADTKD&#46;</p></span>"
        "secciones" => array:5 [
          0 => array:2 [
            "identificador" => "abst0005"
            "titulo" => "Background"
          ]
          1 => array:2 [
            "identificador" => "abst0010"
            "titulo" => "Objective"
          ]
          2 => array:2 [
            "identificador" => "abst0015"
            "titulo" => "Methods"
          ]
          3 => array:2 [
            "identificador" => "abst0020"
            "titulo" => "Results"
          ]
          4 => array:2 [
            "identificador" => "abst0025"
            "titulo" => "Conclusions"
          ]
        ]
      ]
      "es" => array:3 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Antecedentes</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">La esferocitosis hereditaria es un trastorno cl&#237;nica y gen&#233;ticamente heterog&#233;neo&#44; y sus caracter&#237;sticas cl&#237;nicas son esferocitosis&#44; anemia&#44; ictericia y esplenomegalia&#46; Su etiolog&#237;a se asocia con los genes que codifican prote&#237;nas implicadas en la interacci&#243;n entre la membrana de los eritrocitos y la bicapa lip&#237;dica&#46; Las variantes causativas en el gen de la espectrina &#946;I <span class="elsevierStyleItalic">&#40;SPTB&#41;</span> que se presentan como enfermedad entre leve y moderadamente grave son responsables de aproximadamente el 25&#37; de los casos en EE&#46;UU&#46; y Europa&#46; En el contexto de la enfermedad renal se han notificado casos aislados de s&#237;ndrome nefr&#243;tico debido a glomerulonefritis membranoproliferativa y hematuria macrosc&#243;pica con proteinuria debido a nefropat&#237;a por IgA en pacientes con deficiencia de SPTB&#46;</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Objetivo</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Se estudi&#243; a 7 pacientes pertenecientes a una misma familia con esferocitosis para evaluar la insuficiencia renal presente en todos los pacientes adultos afectados&#46;</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Metodolog&#237;a</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Se realizaron investigaciones cl&#237;nicas&#44; radiol&#243;gicas y anal&#237;ticas para evaluar la esferocitosis y la nefropat&#237;a&#46; En una selecci&#243;n de pacientes tambi&#233;n se realizaron an&#225;lisis gen&#233;ticos mediante t&#233;cnicas de secuenciaci&#243;n de nueva generaci&#243;n de genes relacionados con la esferocitosis hereditaria&#44; los trastornos glomerulares hereditarios y la nefropat&#237;a tubulointersticial&#46;</p></span> <span id="abst0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Resultados</span><p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Entre los miembros de la familia con esferocitosis 2 adultos presentaban nefropat&#237;a en fase terminal y uno nefropat&#237;a cr&#243;nica de fase 4&#44; con hallazgos histopatol&#243;gicos inespec&#237;ficos de fibrosis intersticial&#47;atrofia tubular y glomeruloesclerosis&#46; En ese momento no exist&#237;an signos de enfermedad renal en 4 pacientes pedi&#225;tricos&#46; Se detect&#243; una nueva variante sin sentido en el gen <span class="elsevierStyleItalic">SPTB</span> &#40;NM&#95;001024858&#59; c&#46;4796G&#62;A&#59; p&#46;Trp1599Ter&#41; en todos los miembros de la familia con esferocitosis y se predijo que era responsable de la enfermedad&#46; Adem&#225;s&#44; todos los pacientes adultos con insuficiencia renal y 2 pacientes pedi&#225;tricos primos de los pacientes iniciales eran heterocig&#243;ticos para la variante del gen <span class="elsevierStyleItalic">UMOD</span> &#40;NM&#95;003361&#46;3&#58;c&#46;552G&#62;C&#44; NP&#95;003352&#46;2&#58;p&#46;Trp184Cys&#41; notificada previamente en los pacientes con nefropat&#237;a tubulointersticial&#46; Los pacientes iniciales no presentaban la variante <span class="elsevierStyleItalic">UMOD</span>&#46;</p></span> <span id="abst0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Conclusiones</span><p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">La presentaci&#243;n conjunta de cualquiera de estos 2 trastornos hereditarios poco frecuentes es extraordinariamente excepcional&#44; mientras que hasta donde alcanza nuestro conocimiento la presentaci&#243;n conjunta de esferocitosis hereditaria y nefropat&#237;a tubulointersticial autos&#243;mica dominante &#40;ADTKD&#41; no se hab&#237;a notificado previamente&#46; No es posible evaluar si las crisis hemol&#237;ticas debidas a la esferocitosis hereditaria influyen en la progresi&#243;n de la nefropat&#237;a relacionada con el gen <span class="elsevierStyleItalic">UMOD</span>&#44; ya que las caracter&#237;sticas de la ADTKD relacionada con el gen <span class="elsevierStyleItalic">UMOD</span>&#44; en general y en la familia objeto del estudio&#44; son extremadamente variables&#46; Sin embargo&#44; la nefropat&#237;a observada en la familia aconseja realizar exploraciones nefrol&#243;gicas regulares en los pacientes pedi&#225;tricos positivos para UMOD de la familia&#44; con el objetivo de reconocer la hiperuricemia y tratarla lo antes posible&#46; Esto enfatiza la importancia de la detecci&#243;n del &#225;cido &#250;rico s&#233;rico en las pruebas anal&#237;ticas rutinarias de los pacientes pedi&#225;tricos para identificar s&#237;ntomas tempranos de lesiones tubulares indicativas de una posible ADTKD&#46;</p></span>"
        "secciones" => array:5 [
          0 => array:2 [
            "identificador" => "abst0030"
            "titulo" => "Antecedentes"
          ]
          1 => array:2 [
            "identificador" => "abst0035"
            "titulo" => "Objetivo"
          ]
          2 => array:2 [
            "identificador" => "abst0040"
            "titulo" => "Metodolog&#237;a"
          ]
          3 => array:2 [
            "identificador" => "abst0045"
            "titulo" => "Resultados"
          ]
          4 => array:2 [
            "identificador" => "abst0050"
            "titulo" => "Conclusiones"
          ]
        ]
      ]
    ]
    "apendice" => array:1 [
      0 => array:1 [
        "seccion" => array:1 [
          0 => array:4 [
            "apendice" => "<p id="par0095" class="elsevierStylePara elsevierViewall">The following are the supplementary data to this article&#58;<elsevierMultimedia ident="upi0005"></elsevierMultimedia></p>"
            "etiqueta" => "Appendix A"
            "titulo" => "Supplementary data"
            "identificador" => "sec0065"
          ]
        ]
      ]
    ]
    "multimedia" => array:6 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Fig&#46; 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 2220
            "Ancho" => 2496
            "Tamanyo" => 265162
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">A three-generation family tree with clinical manifestations and observed <span class="elsevierStyleItalic">SPTB</span> and <span class="elsevierStyleItalic">UMOD</span> gene variants&#46; Index patients are ilustrated with arrows&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Fig&#46; 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1133
            "Ancho" => 1508
            "Tamanyo" => 213644
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Photomicrograph of standard May-Gr&#252;nwald Giemsa stained peripheral blood smear &#40;100&#215;&#41; of the patient III-1 showing spherocytes &#40;a&#41;&#44; Howell-Jolly bodies &#40;b&#41; and basophic stippling of erythrocyte &#40;c&#41;&#46;</p>"
        ]
      ]
      2 => array:7 [
        "identificador" => "fig0015"
        "etiqueta" => "Fig&#46; 3"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr3.jpeg"
            "Alto" => 680
            "Ancho" => 905
            "Tamanyo" => 127952
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Pathology picture of the affected kidney biopsy in the father &#40;II-2&#41; of the probands&#58; diffuse interstitial fibrosis and tubular atrophy with scarce interstitial infiltrate&#44; and glomerulosclerosis &#40;Perodic acid-Schiff&#44; 100&#215;&#41;&#46;</p>"
        ]
      ]
      3 => array:7 [
        "identificador" => "fig0020"
        "etiqueta" => "Fig&#46; 4"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr4.jpeg"
            "Alto" => 1380
            "Ancho" => 907
            "Tamanyo" => 346603
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">Pathology picture of the affected kidney biopsy in the family member &#40;II-3&#41;&#58; &#40;A&#41; Segmental glomerulosclerosis and pericapsular fibrosis accompanied by interstitial fibrosis and tubular atrophy &#40;Periodic acid-Schiff stain&#44; 100&#215;&#41;&#46; &#40;B&#41; Marked tubular atrophy in medulla &#40;Trichrome stain&#44; 100&#215;&#41;&#46;</p>"
        ]
      ]
      4 => array:7 [
        "identificador" => "fig0025"
        "etiqueta" => "Fig&#46; 5"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr5.jpeg"
            "Alto" => 1154
            "Ancho" => 2169
            "Tamanyo" => 163584
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">Kidney disease development in patients I-1&#44; II-2&#44; II-3 over their life span&#46;</p>"
        ]
      ]
      5 => array:5 [
        "identificador" => "upi0005"
        "tipo" => "MULTIMEDIAECOMPONENTE"
        "mostrarFloat" => false
        "mostrarDisplay" => true
        "Ecomponente" => array:2 [
          "fichero" => "mmc1.pdf"
          "ficheroTamanyo" => 448165
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:19 [
            0 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Hereditary spherocytosis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "S&#46; Perrotta"
                            1 => "P&#46;G&#46; Gallagher"
                            2 => "N&#46; Mohandas"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(08)61588-3"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2008"
                        "volumen" => "372"
                        "paginaInicial" => "1411"
                        "paginaFinal" => "1426"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18940465"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0105"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Variable clinical severity of hereditary spherocytosis&#58; relation to erythrocytic spectrin concentration&#44; osmotic fragility&#44; and autohemolysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "S&#46;W&#46; Eber"
                            1 => "R&#46; Armbrust"
                            2 => "W&#46; Schr&#246;ter"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0022-3476(05)81081-9"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Pediatr"
                        "fecha" => "1990"
                        "volumen" => "117"
                        "paginaInicial" => "409"
                        "paginaFinal" => "416"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2391596"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0110"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Molecular genetic mechanisms of hereditary spherocytosis&#58; current perspectives"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "B&#46;H&#46; Lin"
                            1 => "L&#46;Z&#46; Deng"
                            2 => "Y&#46;T&#46;Y&#46; Xu"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1159/000486229"
                      "Revista" => array:6 [
                        "tituloSerie" => "Acta Haematol"
                        "fecha" => "2018"
                        "volumen" => "139"
                        "paginaInicial" => "60"
                        "paginaFinal" => "66"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29402830"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0115"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A de novo 1&#46;5<span class="elsevierStyleHsp" style=""></span>Mb microdeletion on chromosome 14q23&#46;2-23&#46;3 in a patient with autism and spherocytosis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46;J&#46; Griswold"
                            1 => "D&#46; Ma"
                            2 => "S&#46;J&#46; Sacharow"
                            3 => "J&#46;L&#46; Robinson"
                            4 => "J&#46;M&#46; Jaworski"
                            5 => "H&#46;H&#46; Wright"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/aur.186.A"
                      "Revista" => array:6 [
                        "tituloSerie" => "Autism Res"
                        "fecha" => "2012"
                        "volumen" => "4"
                        "paginaInicial" => "221"
                        "paginaFinal" => "227"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21360829"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0120"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A 2&#46;1<span class="elsevierStyleHsp" style=""></span>Mb deletion adjacent but distal to a 14q21q23 paracentric inversion in a family with spherocytosis and severe learning difficulties"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "H&#46; Lyb&#230;k"
                            1 => "N&#46; &#216;yen"
                            2 => "L&#46; Fauske"
                            3 => "G&#46; Houge"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1399-0004.2008.01072.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Genet"
                        "fecha" => "2008"
                        "volumen" => "74"
                        "paginaInicial" => "553"
                        "paginaFinal" => "559"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18717686"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0125"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Recurrent fatal hydrops fetalis associated with a nucleotide substitution in the erythrocyte &#946;-spectrin gene"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "P&#46;G&#46; Gallagher"
                            1 => "S&#46;A&#46; Weed"
                            2 => "W&#46;T&#46; Tse"
                            3 => "L&#46; Benoit"
                            4 => "J&#46;S&#46; Morrow"
                            5 => "S&#46;L&#46; Marchesi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1172/JCI117766"
                      "Revista" => array:5 [
                        "tituloSerie" => "J Clin Invest"
                        "fecha" => "1995"
                        "volumen" => "95"
                        "paginaInicial" => "1174"
                        "paginaFinal" => "1182"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0130"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Hereditary spherocytosis with nephrotic syndrome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "A&#46; Mathew"
                            1 => "J&#46; Varghese"
                            2 => "G&#46; Kurian"
                            3 => "V&#46; Unni"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Indian J Nephrol"
                        "fecha" => "2007"
                        "volumen" => "17"
                        "paginaInicial" => "174"
                        "paginaFinal" => "175"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0135"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Kidney diseases hereditary spherocytosis with immunoglobulin A nephropathy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "N&#46;K&#46; Biyikli"
                            1 => "I&#46; Gokce"
                            2 => "F&#46; Cakalagaoglu"
                            3 => "E&#46; Turkkan"
                            4 => "H&#46; Alpay"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Iran J Kidney Dis"
                        "fecha" => "2010"
                        "volumen" => "4"
                        "paginaInicial" => "78"
                        "paginaFinal" => "81"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20081310"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0140"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Standards and guidelines for the interpretation of sequence variants&#58; a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46; Richards"
                            1 => "N&#46; Aziz"
                            2 => "S&#46; Bale"
                            3 => "D&#46; Bick"
                            4 => "S&#46; Das"
                            5 => "J&#46; Gastier-Foster"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/gim.2015.30"
                      "Revista" => array:6 [
                        "tituloSerie" => "Genet Med"
                        "fecha" => "2015"
                        "volumen" => "17"
                        "paginaInicial" => "405"
                        "paginaFinal" => "424"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25741868"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0145"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Human Gene Mutation Database&#46; <a target="_blank" href="http://www.hgmd.org/">http&#58;&#47;&#47;www&#46;hgmd&#46;org&#47;</a> &#91;accessed 14&#46;08&#46;19&#93;&#46;"
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0150"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Renal abnormalities in sickle cell disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "P&#46;-T&#46;T&#46; Pham"
                            1 => "P&#46;-C&#46;T&#46; Pham"
                            2 => "A&#46;H&#46; Wilkinson"
                            3 => "S&#46;Q&#46; Lew"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1046/j.1523-1755.2000.00806.x"
                      "Revista" => array:5 [
                        "tituloSerie" => "Kidney Int"
                        "fecha" => "2000"
                        "volumen" => "57"
                        "paginaInicial" => "1"
                        "paginaFinal" => "8"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0155"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "S&#46; Baddam"
                            1 => "I&#46; Aban"
                            2 => "L&#46; Hilliard"
                            3 => "T&#46; Howard"
                            4 => "D&#46; Askenazi"
                            5 => "J&#46;D&#46; Lebensburger"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s00467-017-3623-6"
                      "Revista" => array:5 [
                        "tituloSerie" => "Pediatr Nephrol"
                        "fecha" => "2017"
                        "volumen" => "32"
                        "paginaInicial" => "1451"
                        "paginaFinal" => "1456"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0160"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The initiation and progression of sickle cell nephropathy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "D&#46;E&#46; Wesson"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1046/j.1523-1755.2002.00363.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Kidney Int"
                        "fecha" => "2002"
                        "volumen" => "61"
                        "paginaInicial" => "2277"
                        "paginaFinal" => "2286"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12028473"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0165"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Hemoglobin inhibits albumin uptake by proximal tubule cells&#58; implications for sickle cell disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "M&#46;L&#46; Eshbach"
                            1 => "A&#46; Kaur"
                            2 => "Y&#46; Rbaibi"
                            3 => "J&#46; Tejero"
                            4 => "O&#46;A&#46; Weisz"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1152/ajpcell.00021.2017"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Physiol Cell Physiol"
                        "fecha" => "2017"
                        "volumen" => "312"
                        "paginaInicial" => "C733"
                        "paginaFinal" => "C740"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28356267"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0170"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Phenotype and outcome in hereditary tubulointerstitial nephritis secondary to UMOD mutations"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46; Boll&#233;e"
                            1 => "K&#46; Dahan"
                            2 => "M&#46; Flamant"
                            3 => "V&#46; Moriniere"
                            4 => "A&#46; Pawtowski"
                            5 => "L&#46; Heidet"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2215/CJN.01220211"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin J Am Soc Nephrol"
                        "fecha" => "2011"
                        "volumen" => "6"
                        "paginaInicial" => "2429"
                        "paginaFinal" => "2438"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21868615"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0175"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Alterations of uromodulin biology&#58; a common denominator of the genetically heterogeneous FJHN&#47;MCKD syndrome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "P&#46; Vylet&#8217;al"
                            1 => "M&#46; Kublov&#225;"
                            2 => "M&#46; Kalb&#225;&#269;ov&#225;"
                            3 => "K&#46; Hoda&#328;ov&#225;"
                            4 => "V&#46; Bare&#353;ov&#225;"
                            5 => "B&#46; Stib&#367;rkov&#225;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/sj.ki.5001728"
                      "Revista" => array:6 [
                        "tituloSerie" => "Kidney Int"
                        "fecha" => "2006"
                        "volumen" => "70"
                        "paginaInicial" => "1155"
                        "paginaFinal" => "1169"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16883323"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0180"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Diagnostic approaches for inherited hemolytic anemia in the genetic era"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "Y&#46; Kim"
                            1 => "J&#46; Park"
                            2 => "M&#46; Kim"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.5045/br.2017.52.2.84"
                      "Revista" => array:6 [
                        "tituloSerie" => "Blood Res"
                        "fecha" => "2017"
                        "volumen" => "52"
                        "paginaInicial" => "84"
                        "paginaFinal" => "94"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28698843"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0185"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Autosomal dominant tubulo-interstitial kidney disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "A&#46; Bleyer"
                            1 => "K&#46; Kidd"
                            2 => "M&#46; &#381;ivn&#225;"
                            3 => "S&#46; Kmoch"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1053/j.ackd.2016.11.012"
                      "Revista" => array:5 [
                        "tituloSerie" => "Adv Chronic Kidney Dis"
                        "fecha" => "2017"
                        "volumen" => "118"
                        "paginaInicial" => "86"
                        "paginaFinal" => "93"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0190"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Early treatment with allopurinol in familial juvenile hyerpuricaemic nephropathy &#40;FJHN&#41; ameliorates the long-term progression of renal disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "L&#46; Fairbanks"
                            1 => "J&#46; Cameron"
                            2 => "G&#46; Venkat-Raman"
                            3 => "S&#46; Rigden"
                            4 => "L&#46; Rees"
                            5 => "W&#46; Van&#8217;T Hoff"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/qjmed/95.9.597"
                      "Revista" => array:5 [
                        "tituloSerie" => "Q J Med"
                        "fecha" => "2002"
                        "volumen" => "95"
                        "paginaInicial" => "597"
                        "paginaFinal" => "607"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/02116995/0000004000000004/v2_202009020626/S0211699520300047/v2_202009020626/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "42448"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Originales"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/0000004000000004/v2_202009020626/S0211699520300047/v2_202009020626/en/main.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699520300047?idApp=UINPBA000064"
]
Compartir
Información de la revista
Vol. 40. Núm. 4.julio - agosto 2020
Páginas 371-490
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
6477
Vol. 40. Núm. 4.julio - agosto 2020
Páginas 371-490
Original article
Open Access
SPTB related spherocytosis in a three-generation family presenting with kidney failure in adulthood due to co-occurrence of UMOD disease causing variant
Esferocitosis relacionada con SPTB en tres generaciones de una familia con insuficiencia cardíaca en la edad adulta debido a la presentación conjunta de la variante de UMOD causante de la enfermedad
Visitas
6477
Anamarija Meglica, Marusa Debeljakb, Jernej Kovacb, Alenka Trampus Bakijab, Vladan Rajicc, Nika Kojcd, Katarina Trebusak Podkrajsekb,e,
Autor para correspondencia
a University Medical Centre Ljubljana, University Children's Hospital, Department of Nephrology, Ljubljana, Slovenia
b University Medical Centre Ljubljana, University Children's Hospital, Institute for Special Laboratory Diagnostics, Ljubljana, Slovenia
c University Medical Centre Ljubljana, University Children's Hospital, Department of Haematology and Oncology, Ljubljana, Slovenia
d University of Ljubljana, Faculty of Medicine, Institute of Pathology, Ljubljana, Slovenia
e University of Ljubljana, Faculty of Medicine, Institute of Biochemistry, Ljubljana, Slovenia
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (5)
Mostrar másMostrar menos
Material adicional (1)
Abstract
Background

Hereditary spherocytosis is clinically and genetically heterogeneous disorder and its clinical characteristics are spherocytosis, anaemia, jaundice and splenomegaly. The aetiology is associated to the genes encoding proteins involved in the interaction between the erythrocyte membrane and the lipid bilayer. Causative variants in βI-spectrin (SPTB) gene presenting as mild to moderately severe disease are responsible for approximately 25% cases in the USA and Europe. Among kidney disease, isolated cases of nephrotic syndrome due to membranoproliferative glomerulonephritis and macroscopic haematuria with proteinuria due to IgA nephropathy were previously reported in patients with SPTB deficiency.

Objective

Seven patients from the same family with spherocytosis were evaluated to assess the kidney failure presented in all affected adult patients.

Methods

Clinical, radiological and laboratory investigations were issued to evaluate the spherocytosis and kidney disease. In selected patients, we also performed genetics testing with next generation sequencing of genes related to hereditary spherocytosis, inherited glomerular disorders and tubulo-interstitial kidney disease.

Results

Among the family members with spherocytosis, two adults had end-stage kidney disease and one chronic kidney disease stage 4 with unspecific histopathological findings of interstitial fibrosis/tubular atrophy and glomerulosclerosis. At the time, there were no signs of kidney disease present in four paediatric patients. Novel nonsense variant in SPTB gene (NM_001024858; c.4796G>A; p.Trp1599Ter) was detected in all family members with spherocytosis and was predicted to be disease causing. Furthermore, all adult patients with kidney failure and two paediatric cousins of the index patients were heterozygous for the UMOD gene variant (NM_003361.3:c.552G>C, NP_003352.2:p.Trp184Cys) previously reported in patients with tubulo-interstitial kidney disease. UMOD variant was not present in the index patients.

Conclusions

The co-occurrence of any two rare inherited disorders is extremely rare, while to our knowledge the co-occurrence of genetically confirmed HS and autosomal dominant tubulo-interstitial kidney disease (ADTKD) has previously not been reported. It is not possibly to evaluate whether the haemolytic crises due to HS are influencing the progression of the UMOD related renal disease, since the UMOD related ADTKD characteristics in general and in here presented family are extremely variable. Nevertheless, the observed kidney disease in the family is warranting the regular nephrological examinations in UMOD positive paediatric patients in the family in order to recognise hyperuricemia and treat it as early as possible. This is emphasising the importance of serum uric acid detection in routine laboratory screening of paediatric patients in order to identify early signs of tubular injury indicating possible ADTKD.

Keywords:
Hereditary spherocytosis
Tubulo-interstitial kidney disease
βI-spectrin
UMOD
Chronic kidney disease
Next generation sequencing
Abbreviations:
ANK1
ADTKD
BUN
CKD
EPB42
FSGS
GFR
HS
NGS
SCD
SPTA1
SPTB
SLC4A1
Resumen
Antecedentes

La esferocitosis hereditaria es un trastorno clínica y genéticamente heterogéneo, y sus características clínicas son esferocitosis, anemia, ictericia y esplenomegalia. Su etiología se asocia con los genes que codifican proteínas implicadas en la interacción entre la membrana de los eritrocitos y la bicapa lipídica. Las variantes causativas en el gen de la espectrina βI (SPTB) que se presentan como enfermedad entre leve y moderadamente grave son responsables de aproximadamente el 25% de los casos en EE.UU. y Europa. En el contexto de la enfermedad renal se han notificado casos aislados de síndrome nefrótico debido a glomerulonefritis membranoproliferativa y hematuria macroscópica con proteinuria debido a nefropatía por IgA en pacientes con deficiencia de SPTB.

Objetivo

Se estudió a 7 pacientes pertenecientes a una misma familia con esferocitosis para evaluar la insuficiencia renal presente en todos los pacientes adultos afectados.

Metodología

Se realizaron investigaciones clínicas, radiológicas y analíticas para evaluar la esferocitosis y la nefropatía. En una selección de pacientes también se realizaron análisis genéticos mediante técnicas de secuenciación de nueva generación de genes relacionados con la esferocitosis hereditaria, los trastornos glomerulares hereditarios y la nefropatía tubulointersticial.

Resultados

Entre los miembros de la familia con esferocitosis 2 adultos presentaban nefropatía en fase terminal y uno nefropatía crónica de fase 4, con hallazgos histopatológicos inespecíficos de fibrosis intersticial/atrofia tubular y glomeruloesclerosis. En ese momento no existían signos de enfermedad renal en 4 pacientes pediátricos. Se detectó una nueva variante sin sentido en el gen SPTB (NM_001024858; c.4796G>A; p.Trp1599Ter) en todos los miembros de la familia con esferocitosis y se predijo que era responsable de la enfermedad. Además, todos los pacientes adultos con insuficiencia renal y 2 pacientes pediátricos primos de los pacientes iniciales eran heterocigóticos para la variante del gen UMOD (NM_003361.3:c.552G>C, NP_003352.2:p.Trp184Cys) notificada previamente en los pacientes con nefropatía tubulointersticial. Los pacientes iniciales no presentaban la variante UMOD.

Conclusiones

La presentación conjunta de cualquiera de estos 2 trastornos hereditarios poco frecuentes es extraordinariamente excepcional, mientras que hasta donde alcanza nuestro conocimiento la presentación conjunta de esferocitosis hereditaria y nefropatía tubulointersticial autosómica dominante (ADTKD) no se había notificado previamente. No es posible evaluar si las crisis hemolíticas debidas a la esferocitosis hereditaria influyen en la progresión de la nefropatía relacionada con el gen UMOD, ya que las características de la ADTKD relacionada con el gen UMOD, en general y en la familia objeto del estudio, son extremadamente variables. Sin embargo, la nefropatía observada en la familia aconseja realizar exploraciones nefrológicas regulares en los pacientes pediátricos positivos para UMOD de la familia, con el objetivo de reconocer la hiperuricemia y tratarla lo antes posible. Esto enfatiza la importancia de la detección del ácido úrico sérico en las pruebas analíticas rutinarias de los pacientes pediátricos para identificar síntomas tempranos de lesiones tubulares indicativas de una posible ADTKD.

Palabras clave:
Esferocitosis hereditaria
Nefropatía tubulointersticial
Gen de la espectrina βI
UMOD
Nefropatía crónica
Secuenciación de nueva generación
Texto completo
Introduction

Hereditary spherocytosis (HS) is a common type of hereditary haemolytic anaemia. It is clinically and genetically heterogeneous disorder, with spherocytosis, anaemia, jaundice and splenomegaly as typical clinical characteristics.1 Clinical severity is variable with most patients having a well-compensated haemolytic anaemia. Some individuals are asymptomatic, whereas others have severe haemolytic anaemia requiring erythrocyte transfusion. Patients are classified by clinical features as severe, moderate or mild using the criteria establish by Eber SW.2 The assessment should be issued when the patient is in a stable baseline state, as with the undercurrent illness the severity may be overestimated. Children with severe HS are rare (about 5%). They are constantly anaemic and may be transfusion dependent, especially in the first few years of life.

The primary causes of the disease are abnormalities of the red blood cell membrane structural proteins leading to the loss of membrane surface area, erythrocytes deformability and decrease of stability, finally resulting in haemolysis. The aetiology is related to the genes encoding proteins involved in the interaction between the erythrocyte membrane and the lipid bilayer, namely ankyrin (ANK1), α1-spectrin (SPTA1), βI-spectrin (SPTB), band 3 (SLC4A1) and protein 4.2 (EPB42).3 Variants in SPTB gene are causing HS type 2 (MIM#616649) and are inherited in an autosomal dominant manner. They are responsible for approximately 25% of HS cases in the United States of America and Europe presenting with mild to moderately severe disease where transfusion is usually not needed.1,3 Sporadically, large genomic deletions of SPTB gene were associated to psychomotor developmental delay and autism4,5 while SPTB gene substitution was associated to prenatal hydrops fetalis.6 Additionally, variants in SPTB gene were associated to hereditary elliptocytosis (MIM#617948). Among kidney disease, isolated cases of nephrotic syndrome due to membranoproliferative glomerulonephritis7 and macroscopic haematuria with proteinuria due to IgA nephropathy8 were reported in patients with HS. Here we present a three-generation family with seven patients with spherocytosis due to the novel variant in SPTB gene (NM_001024858; c.4796G>A; p.Trp1599Ter). Among the patients in the family, two adults had end-stage kidney disease and one chronic kidney disease (CKD) stage 4 with histopathologicaly unspecific findings of interstitial fibrosis and focal segmental glomerulosclerosis (FSGS) that was later on attributed to tubulo-interstitial kidney disease due to disease causing UMOD variant.

Material and methodsPatients

Initially, two Slovenian paediatric patients with spherocytosis were referred to the paediatric nephrologist at the outpatient clinic of the Department for Nephrology at the University Children's Hospital in Ljubljana, Slovenia, because of the positive family history of CKD in their father, paternal grandmother and uncle. After initial clinical examination, we issued standard laboratory and radiological investigations to evaluate the kidney function, electrolytic disturbances, acid-base status and red blood cell status properties. Additionally, detailed family history regarding renal and haematological diseases was assessed. Later on, all seven affected family members were invited for additional evaluation. Participants consented to the study, which was conducted according to the principles in the Declaration of Helsinki.

Genetic analysis

Genomic DNA of all affected family members was isolated from peripheral blood samples using FlexiGene DNA isolation kit (Qiagen, Hilden, Germany). To evaluate the genetic cause of the spherocytosis and CKD in the family a targeted next generation sequencing (NGS) was conducted in both siblings and their affected father and paternal grandmother. We used TruSightOne Sequencing Panel on the MiSeq platform desktop sequencer coupled with MiSeq Reagent kit v3 (all Illumina, USA) followed by on-board primary analysis. A list of rare genetic variants (minor allele frequency <1%) in 5 genes related to HS, 51 genes related to inherited glomerular disorders with FSGS or 4 genes related to autosomal dominant tubulo-interstitial kidney disease (ADTKD) (Supplementary material 1) was filtered with Variant Studio 2.3 software (Illumina, USA). Variants that were identified as possibly causative were confirmed by targeted Sanger sequencing using custom oligonucleotides, BigDye Terminator v3.1 sequencing kit and ABI Genetic Analyser 3500 (both Applied Biosystems, USA) in all family members.

ResultsPatients

Family pedigree with major clinical manifestations and detected disease-causing variants was summarised in Fig. 1. All family members with spherocytosis had 1–6% of spherocytes in the peripheral blood smear. Additionally, Howell Jolley bodies and occasional basophile punctuations were present (Fig. 2). Mean cell volume (MCV) values were lower than in normal population ranged from 74 to 86fL and median haemoglobin concentrations were 116g/L (95–163). Osmotic fragility test showed increased RBC membrane fragility with tailed sigmoid curve in all patients with HS but patients II-1 and III-4, while RBC band 3 protein fluorescence staining with eosin-5-maleimide (EMA) was significantly decreased in all patients.

Fig. 1.

A three-generation family tree with clinical manifestations and observed SPTB and UMOD gene variants. Index patients are ilustrated with arrows.

(0.25MB).
Fig. 2.

Photomicrograph of standard May-Grünwald Giemsa stained peripheral blood smear (100×) of the patient III-1 showing spherocytes (a), Howell-Jolly bodies (b) and basophic stippling of erythrocyte (c).

(0.2MB).

Both initially evaluated siblings (subject III-1 and III-2) had normal kidney function and blood pressure, no proteinuria or haematuria, no electrolytic disturbances or acid-base status abnormalities. The ultrasound exam of urinary tract was normal. The older sibling, 16-year-old girl (subject III-1) had so far only one haemolytic crisis that needed transfusion, the younger, 12-year-old boy (subject III-2) had none.

Nephrologist followed the children's 42-year-old father with spherocytosis (subject II-2) due to deterioration of the renal function with hypertension. Splenectomy was performed when he was 22 years old, after one of the many haemolytic crises. After splenectomy haemolytic crises did not repeat. He had hyperuricemia without clinical presentation of gout. When renal biopsy was performed, glomerular filtration rate (GFR) 17ml/min/1.73m2, electrolyte imbalance of potassium and phosphate were described and mild proteinuria (520mg/day). By ultrasonography, his kidney appeared hyper-echogenic and were smaller than expected for an adult male (8cm). Histopathological findings showed rather unspecific changes including diffuse 70% interstitial fibrosis and tubular atrophy with scarce interstitial infiltrate composed of lymphocytes and monocytes, and advanced glomerulosclerosis in 75% of glomeruli (70% global glomerulosclerosis and 5% segmental glomerulosclerosis) (Fig. 3), while no cysts were detected. Electron microscopy revealed normal ultrastructure of glomerular basement membrane with minimal segmental 5% podocyte effacement. Immunofluorescence was unremarkable. He had kidney transplantation three years later, following few months of dialysis. Protocol biopsy one year after transplantation revealed well-functioning kidney graft without signs of rejection, his uric acid was normal without therapy.

Fig. 3.

Pathology picture of the affected kidney biopsy in the father (II-2) of the probands: diffuse interstitial fibrosis and tubular atrophy with scarce interstitial infiltrate, and glomerulosclerosis (Perodic acid-Schiff, 100×).

(0.12MB).

The siblings’ paternal grandmother with spherocytosis (subject I-1) had splenectomy when she was about 40 years old. She started with dialysis when she was about 55 years old. She had hyperuricemia that was well controlled by allopurinol and diet. At age of 58, she had kidney transplantation and experienced T-cell mediated rejection 4 months later. She presented with Pneumocystis jirovecii pneumonia and CMV disease resulting in decrease of immunosuppressive therapy and finally lost her graft 3 years after transplantation due to chronic active T-cell and vascular rejection. At the time, she had no follow-up by the nephrologist before the kidney failure, no renal biopsy and there is no available data regarding prior development of her kidney disease. Recently she had passed away due to a stroke in her seventies.

Another family member, 32-year-old uncle of the siblings, namely their father's brother (subject II-3), had splenectomy at age of 12 after several mild haemolytic crises. Later on, the diagnosis of CKD was set. He had gout with many attacks despite of allopurinol therapy and diet. Light microscopy detected 40% interstitial fibrosis and tubular atrophy affecting cortex and medulla with lack of functioning tubules particularly in medulla without any cysts. Accompanied 25% glomerulosclerosis and pericapsular fibrosis of glomeruli indicated secondary involvement due to tubulointerstitial damage (Fig. 4). Immunofluorescence was unremarkable. Additionally, his 2-year- and 4-year-old sons (subjects III-3 and III-4) had spherocytosis with no haemolytic crisis so far and no clinical or echocardiographic signs of kidney disease. Their creatinine clearances were normal, they had no proteinuria, but both had high serum uric acid levels and low fractional excretions of urinary uric acid. Detailed description of CKD development in adult patients over their life span was summarised in Fig. 5.

Fig. 4.

Pathology picture of the affected kidney biopsy in the family member (II-3): (A) Segmental glomerulosclerosis and pericapsular fibrosis accompanied by interstitial fibrosis and tubular atrophy (Periodic acid-Schiff stain, 100×). (B) Marked tubular atrophy in medulla (Trichrome stain, 100×).

(0.33MB).
Fig. 5.

Kidney disease development in patients I-1, II-2, II-3 over their life span.

(0.16MB).
Genetic analysis

The analysis revealed that both index patients, their father, paternal grandmother, father's younger brother and his two children were heterozygous for the SPTB variant NM_001024858:c.4796G>A resulting in premature termination codon at the position 1599 (NP_001020029.1:p.Trp1599Ter) (Fig. 1). The variant had so far not been reported in patients with spherocytosis nor in apparently healthy population while in silico tools were predicting it to be pathological (Mutation taster, CADD score 45). According to the ACMG/AMP 2015 guidelines9 the variant was classified as pathological with the following grades: PVS1 (null variant), PM2 (absent from general population), PP1 (co-segregation with the disease in multiple affected family members in gene definitely known to cause the disease), PP3 (multiple lines of computational evidence supporting the deleterious effect). Additionally, we performed NGS based analysis of genes related to inherited glomerular disorders and ADTKD. Father of the index patients, paternal grandmother, father's brother and his two children were heterozygous for the UMOD variant NM_003361.3:c.552G>C resulting in substitution of tryptophan to cysteine at the position 184 (NP_003352.2:p.Trp184Cys) (Fig. 1). This variant has already been reported in patients with ADTKD (HGMD acc. nr. CM118889)10 and was not present in index patients nor in their mother.

Discussion

HS is a common type of hereditary haemolytic anaemia, rarely accompanied by renal manifestations.7 We present a family with seven members presenting with HS due to the novel SPTB variant p.Trp1599Ter suspected to cause βI-spectrin deficiency. In the same family, all three affected adult family members had CKD that was later on attributed to the known UMOD gene variant p.Trp184Cys.

Contrary to the HS in sickle cell disease (SCD), another type of haemolytic anaemia, numerous renal syndromes were described, including increased GFR, acute renal failure, renal tubular disease, chronic renal insufficiency, renal tubular acidosis and others as reviewed in Pham et al.11 Acute kidney injury during SCD pain crisis may be an important risk factor for developing CKD.12 Development of kidney disease in SCD is not fully elucidated. It is associated with oxidative stress caused by the vaso-occlusive episodes, ischaemia-reperfusion injury and the associated chronic inflammatory response, glomerular hyperfiltration and chronic exposure of renal tubular epithelium to high levels of filtered plasma proteins due to proteinuria, as reviewed by Wesson.13 Proximal tubule dysfunction, including tubular proteinuria, is a significant complication in SCD that can eventually lead to CKD. Haemoglobin dimers released from red blood cells upon haemolysis are filtered into the kidney and internalised by megalin/cubilin receptors into proximal tubule cells. Proximal tubule cells are especially sensitive to haem toxicity and tubular dysfunction in SCD is thought to result from prolonged exposure to filtered hemoglobine.14 The mechanism behind the development of kidney disease in HS is not clear and might be related to the mechanism in SCD, since haemolytic crisis are probably the initiators of its development in both cases. Involvement of renal cortex and medulla in the absence of other known causes of medullary tissue remodelling (diabetes, chronic infections, NSAIDS and congenital disorders) suggested haemolysis as one of the potentially pathogenic mechanism of tubular and/or vascular injury leading to interstitial fibrosis and secondary glomerulosclerosis.

In here presented family, we initially speculated that haem toxicity was the cause of the CKD, especially since it had an onset in the adulthood after many haemolytic crises. Nevertheless, to eliminate the less probable existence of additional genetic factors that could contribute to the co-occurrence of the renal disease, we have analysed genes associated to the inherited glomerular disorders and ADTKD. To our surprise, we have identified a variant p.Trp184Cys in UMOD gene in all three adult patients with kidney failure. It was previously reported in 3 members of a Caucasian family with ADTKD, but their clinical presentation was not individually described.15 In general, early onset hyperuricemia is a hallmark of the ADTKD due to UMOD deficiency, where renal survival and clinical characteristic are extremely variable even in patients in the same family. Disease causing UMOD variants are resulting in deficient production of functional uromodulin normally expressed in tubular cells and intracellular deposition of mutant uromodulin. This is leading to accelerated tubular damage and consequently end-stage renal kidney disease.16 Renal biopsy in two adult patients revealed rather unspecific histological changes including interstitial fibrosis, tubular atrophy, glomerulosclerosis and normal podocytes without foot process effacement even in advanced chronic tubulointerstitial changes, which pointed towards tubules/interstitium as primarily affected compartment and is in accordance with the UMOD deficiency. They presented with low proteinuria suggesting FSGS as secondary glomerular changes due to hyperfiltration in remaining overloaded glomeruli. Other risk factors (i.e.: low birth weight, renal asymmetry, obesity, drugs, inherited glomerular disorders) for FSGS development were not present. In addition, two paediatric patients, namely subjects III-3 and III-4, had the same UMOD disease-causing variant. Currently they have no reported haemolytic crises and normal kidney function, but both have high serum uric acid, low fractional excretion of urinary uric acid and low serum uromodulin level confirming deficient production of functional uromodulin.

NGS based genetic testing approach has proved useful as a first-line approach in identification of the genetic aetiology of inherited haemolytic anaemias where several genes can be candidates to be causative.17 Furthermore, in cases with complex clinical manifestations that cannot be directly attributed to one disorder NGS enables analysis of all genes associated to individual manifestation in the same experiment without the need of the strict preselection. This proofed to be extremely valuable in here reported family with co-occurrence of two rare inherited disorders with the clinical onset in different stages of life. Furthermore, the importance of the valid clinical evaluation of the index patients and their family members prior the NGS analysis is well recognised. In here presented family it was crucial since index patients had no kidney disease, but the genetic and clinical evaluation of the family enabled recognition of UMOD related ADTKD in their junior cousins with currently normal kidney function. Consequently, their renal function and serum uric acid level will be closely monitored in order to timely introduce hyperuricemia treatment.18,19 This is emphasising the importance of serum uric acid detection in routine laboratory screening of paediatric patients in order to identify early signs of tubular injury indicating possible ADTKD.

Conclusions

The co-occurrence of any two rare inherited disorders is extremely rare, while to our knowledge the co-occurrence of genetically confirmed HS and ADTKD has not been previously reported. It is not possibly to evaluate whether the haemolytic crises due to HS are influencing the progression of the UMOD related renal disease, especially, since the UMOD related kidney disease characteristics in general and in here presented family (Fig. 5) are extremely variable. Nevertheless, the observed kidney disease in the family is warranting the regular nephrological examinations in paediatric patients in the family in order to recognise elevated serum uric acid as the first signs of tubular dysfunction, since early onset of hyperuricemia treatment may slow the progression of subsequent kidney disease. The future clinical course in index patients with HS and their two cousins with co-occurrence of HS and UMOD disease-causing variant will highlight the potential role of UMOD related disease as well as HS on kidney function. Clinical data of five patients of different ages with the co-occurrence of two genetic disorders is extremely valuable and my shed a light on the complex pathophysiology of the genetically based co-morbidity.

Funding

The study was supported by the financial support from the Slovenian Research Agency (research core funding P3-0343 and P1-0170).

Conflict of interest

None.

Appendix A
Supplementary data

The following are the supplementary data to this article:

References
[1]
S. Perrotta, P.G. Gallagher, N. Mohandas.
Hereditary spherocytosis.
Lancet, 372 (2008), pp. 1411-1426
[2]
S.W. Eber, R. Armbrust, W. Schröter.
Variable clinical severity of hereditary spherocytosis: relation to erythrocytic spectrin concentration, osmotic fragility, and autohemolysis.
J Pediatr, 117 (1990), pp. 409-416
[3]
B.H. Lin, L.Z. Deng, Y.T.Y. Xu.
Molecular genetic mechanisms of hereditary spherocytosis: current perspectives.
Acta Haematol, 139 (2018), pp. 60-66
[4]
A.J. Griswold, D. Ma, S.J. Sacharow, J.L. Robinson, J.M. Jaworski, H.H. Wright, et al.
A de novo 1.5Mb microdeletion on chromosome 14q23.2-23.3 in a patient with autism and spherocytosis.
Autism Res, 4 (2012), pp. 221-227
[5]
H. Lybæk, N. Øyen, L. Fauske, G. Houge.
A 2.1Mb deletion adjacent but distal to a 14q21q23 paracentric inversion in a family with spherocytosis and severe learning difficulties.
Clin Genet, 74 (2008), pp. 553-559
[6]
P.G. Gallagher, S.A. Weed, W.T. Tse, L. Benoit, J.S. Morrow, S.L. Marchesi, et al.
Recurrent fatal hydrops fetalis associated with a nucleotide substitution in the erythrocyte β-spectrin gene.
J Clin Invest, 95 (1995), pp. 1174-1182
[7]
A. Mathew, J. Varghese, G. Kurian, V. Unni.
Hereditary spherocytosis with nephrotic syndrome.
Indian J Nephrol, 17 (2007), pp. 174-175
[8]
N.K. Biyikli, I. Gokce, F. Cakalagaoglu, E. Turkkan, H. Alpay.
Kidney diseases hereditary spherocytosis with immunoglobulin A nephropathy.
Iran J Kidney Dis, 4 (2010), pp. 78-81
[9]
S. Richards, N. Aziz, S. Bale, D. Bick, S. Das, J. Gastier-Foster, et al.
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Genet Med, 17 (2015), pp. 405-424
[10]
Human Gene Mutation Database. http://www.hgmd.org/ [accessed 14.08.19].
[11]
P.-T.T. Pham, P.-C.T. Pham, A.H. Wilkinson, S.Q. Lew.
Renal abnormalities in sickle cell disease.
[12]
S. Baddam, I. Aban, L. Hilliard, T. Howard, D. Askenazi, J.D. Lebensburger.
Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis.
Pediatr Nephrol, 32 (2017), pp. 1451-1456
[13]
D.E. Wesson.
The initiation and progression of sickle cell nephropathy.
Kidney Int, 61 (2002), pp. 2277-2286
[14]
M.L. Eshbach, A. Kaur, Y. Rbaibi, J. Tejero, O.A. Weisz.
Hemoglobin inhibits albumin uptake by proximal tubule cells: implications for sickle cell disease.
Am J Physiol Cell Physiol, 312 (2017), pp. C733-C740
[15]
G. Bollée, K. Dahan, M. Flamant, V. Moriniere, A. Pawtowski, L. Heidet, et al.
Phenotype and outcome in hereditary tubulointerstitial nephritis secondary to UMOD mutations.
Clin J Am Soc Nephrol, 6 (2011), pp. 2429-2438
[16]
P. Vylet’al, M. Kublová, M. Kalbáčová, K. Hodaňová, V. Barešová, B. Stibůrková, et al.
Alterations of uromodulin biology: a common denominator of the genetically heterogeneous FJHN/MCKD syndrome.
Kidney Int, 70 (2006), pp. 1155-1169
[17]
Y. Kim, J. Park, M. Kim.
Diagnostic approaches for inherited hemolytic anemia in the genetic era.
Blood Res, 52 (2017), pp. 84-94
[18]
A. Bleyer, K. Kidd, M. Živná, S. Kmoch.
Autosomal dominant tubulo-interstitial kidney disease.
Adv Chronic Kidney Dis, 118 (2017), pp. 86-93
[19]
L. Fairbanks, J. Cameron, G. Venkat-Raman, S. Rigden, L. Rees, W. Van’T Hoff, et al.
Early treatment with allopurinol in familial juvenile hyerpuricaemic nephropathy (FJHN) ameliorates the long-term progression of renal disease.
Q J Med, 95 (2002), pp. 597-607
Copyright © 2020. Sociedad Española de Nefrología
Descargar PDF
Idiomas
Nefrología
Opciones de artículo
Herramientas
Material suplementario
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?